Shanghai Unihealth is going to focus stress on Binax project in 2005.

BINAX, Inc. was founded in 1986, it engages in the research & development of high biotech and manufacturing of products, it spreads its business on rapidly. The major business at present is fast test kits used for the identification of infectious diseases. Since BINAX occupies the advanced leadership on the respect of test of virus antigen with core technology owned by BINAX and its products have the characters of rapid diagnosis and easy use, its products have high reputation and are broadly applied in the field of this industry.

In 2004, in order to make Chinese patients who are obsessed with infectious disease to be treated with the best international product and services synchronistically, Shanghai Unihealth Pharmaceutical International Trade Co., Ltd. successfully became the exclusive agent in China under the authorization of US BINAX, Inc.

The NOW products of US BINAX, Inc include numerous series of high-tech products. Considering the characters of contamination and prevalence of infective diseases in China, and also taking the related factor on the market and application prospect of use into account, Unihealth introduced the following products on the first phase:
1, NOW Influenza A &B for the rapid identification and differentiation of Influenza A and B.
2, NOW Legionella for the Rapid identification of Legionella pneumophila serogroup.
3, NOW RSV for the rapid diagnosis of respiratory syncytial virus.
4, NOW S.pneumoniae for the rapid identification of Streptococcus pneumoniae.
The Product we are actively introducing is:
NOW Gonorrhea for the rapid identification of gonorrhea caused by gonococcus.

According to the statistics from The Ministry of Health in recent years, no matter the respiratory diseases or gonorrhea, the cardinal number of the patients in Mainland, China. And such number is on the rising trend along with the change of natural and social environment. On the basis of the conditions mentioned above, we roughly reckoned that the market scale of various test products in China could reach at least 5 billion yuan RMB every year. Certainly, The accurate market share of which BINAX NOW series products will occupy indeed, should be linked with products market positioning. In fact, Shanghai Unihealth Pharmaceutical International Trade Co., Ltd. is filled with sincerest passion and full confidence on the NOW Products.

It is the outstanding characteristic that the NOW Products are focused on.

Accurate Ratio
For every method of disease identification, the accurate ratio is regarded as the gold standard to develop and practically apply. Resort to the sound high technology of Binax, the accurate ratio of Binax NOW series products had been proven by international examination system and large quantity of clinic inspection around world, these products are being accepted in a wide range in the field of diseases identification.

Convenience of application
As a common hospital in China, if it want to insure validity of methods of disease identification, it needs put a lot of money in to purchase expensive import medical equipment & instrument and many operators should be trained to be professional enough to operate and judge the figures correctly. When the hospitals adopt Binax NOW series products, every thing will be easy, no need of expensive medical equipment or instrument, no need of professional operators, etc. The money and human resource will be saved, and the efficiency will be enhanced greatly.
As a patient, he can exam and judge by himself easily, what he needs to do is just purchase Binax NOW series products form drug store. Then to make the decision if need to see a doctor. The money and time also will be saved, and the efficiency will be enhanced greatly.

Rapid process
Rapid to get result, is a highlight character of Binax NOW series products. It’s no necessary to cost a long time and energy on the rush come and go between job and diagnose. Only 15 min stay in hospital, it’s enough to gain the diagnose result. The money and time also will be saved, and the delay of medical treat will be avoided in time.

Sourcing mentioned above, Binax NOW series products have attracted our eyes with outstanding character. Shanghai Unihealth Pharmaceutical International Trade Co., Ltd. have the honor to recommend such wonderful products to Chinese people, and full filled with confidence on its future space of application in China.

At this time, we must express our thanks to our co-operators and all clients for their support. As to 2005, ours company is going to stand our hope on the support from kind co-operators. Our purpose is to push our performance to a kind of new top level to reach the earnest expectation of Chinese people.